Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$662M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$116M |
| 3 |
Broadcom
AVGO
|
+$96.2M |
| 4 |
Walmart Inc
WMT
|
+$91.2M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$77.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$175M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$152M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$149M |
| 4 |
INFN
Infinera Corporation Common Stock
INFN
|
+$108M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$70.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.92% |
| 2 | Financials | 4.33% |
| 3 | Healthcare | 3.85% |
| 4 | Consumer Discretionary | 3.59% |
| 5 | Industrials | 3.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
CALL
Macy's
M
$6.1B
| $275K | ﹤0.01% |
21,900
+1,000
| +5% | +$14.5K |
|
2652
Community Health Systems
CYH
$424M
| $275K | ﹤0.01% |
101,739
+84,563
| +492% | +$263K |
|
2653
CALL
Tower Semiconductor
TSEM
$23.9B
| $275K | ﹤0.01% |
+7,700
| New | +$348K |
|
2654
CALL
Molson Coors Class B
TAP
$8.02B
| $274K | ﹤0.01% |
4,500
-4,900
| -52% | -$282K |
|
2655
AdvanSix
ASIX
$454M
| $273K | ﹤0.01% |
12,074
+1,064
| +10% | +$29.6K |
|
|
SF
2656
CALL
Stifel
SF
$12.2B
| $273K | ﹤0.01% |
4,350
-750
| -15% | -$52.9K |
|
2657
PUT
Franklin Templeton
BEN
$17.6B
| $273K | ﹤0.01% |
+14,200
| New | +$285K |
|
2658
CALL
Ryder
R
$9.39B
| $273K | ﹤0.01% |
1,900
-1,200
| -39% | -$187K |
|
2659
PUT
NOV
NOV
$7.04B
| $272K | ﹤0.01% |
17,900
+900
| +5% | +$13.5K |
|
2660
CALL
HP
HPQ
$26.1B
| $271K | ﹤0.01% |
9,800
-8,800
| -47% | -$278K |
|
2661
PUT
Brookfield Asset Management
BAM
$83.6B
| $271K | ﹤0.01% |
5,600
-3,400
| -38% | -$185K |
|
|
AKRO
2662
CALL
DELISTED
Akero Therapeutics
AKRO
| $271K | ﹤0.01% |
+6,700
| New | +$284K |
|
|
PPL
2663
CALL
PPL Corp
PPL
$26.4B
| $271K | ﹤0.01% |
+7,500
| New | +$254K |
|
2664
ProShares Bitcoin Strategy ETF
BITO
$1.74B
| $271K | ﹤0.01% |
+14,768
| New | +$321K |
|
2665
CALL
Alnylam Pharmaceuticals
ALNY
$31.6B
| $270K | ﹤0.01% |
1,000
-3,500
| -78% | -$899K |
|
2666
PUT
Principal Financial Group
PFG
$24B
| $270K | ﹤0.01% |
3,200
+200
| +7% | +$16.6K |
|
2667
CALL
Coca-Cola Europacific Partners
CCEP
$48.6B
| $270K | ﹤0.01% |
3,100
+200
| +7% | +$16.3K |
|
2668
PUT
Trane Technologies
TT
$99.7B
| $270K | ﹤0.01% |
800
-300
| -27% | -$108K |
|
2669
PUT
Arch Capital
ACGL
$34.5B
| $269K | ﹤0.01% |
2,800
-5,900
| -68% | -$544K |
|
2670
PUT
McKesson
MCK
$102B
| $269K | ﹤0.01% |
400
-1,500
| -79% | -$927K |
|
2671
PUT
ScottsMiracle-Gro
SMG
$3.53B
| $269K | ﹤0.01% |
+4,900
| New | +$317K |
|
2672
Dorman Products
DORM
$3.89B
| $269K | ﹤0.01% |
+2,231
| New | +$285K |
|
2673
CALL
Legend Biotech
LEGN
$4.07B
| $268K | ﹤0.01% |
7,900
-400
| -5% | -$14.3K |
|
2674
Immatics
IMTX
$1.19B
| $267K | ﹤0.01% |
59,282
+23,630
| +66% | +$123K |
|
2675
CALL
nVent Electric
NVT
$24.8B
| $267K | ﹤0.01% |
+5,100
| New | +$322K |
|
Similar funds
Paul Tudor Jones's Q1 2025 Portfolio in Review
As of Q1 2025, Paul Tudor Jones held 3,818 positions worth $30.1B, up 15% from $26.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Paul Tudor Jones deployed $6.13B of net new capital in Q1 2025, opening 874 new positions and adding to 1,161 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 6.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Bitcoin Trust, an estimated $175M trimmed.
- Paul Tudor Jones's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
- Paul Tudor Jones added most to iShares Russell 2000 ETF in Q1 2025, an estimated $662M increase.
- Paul Tudor Jones's biggest Q1 2025 reduction was iShares Bitcoin Trust, cutting an estimated $175M.
- Paul Tudor Jones fully exited Infinera Corporation Common Stock in Q1 2025, selling an estimated $108M.
- Paul Tudor Jones's ten largest holdings make up 40% of its $30.1B portfolio in Q1 2025.
- Paul Tudor Jones opened 874 new positions and closed 844 in Q1 2025.
- Paul Tudor Jones's portfolio value rose 15% quarter-over-quarter to $30.1B.
Based on Tudor Investment Corp's 13F filing for Q1 2025, filed 15 May 2025.